Ionis Pharmaceuticals IONS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's operating margin?
- Ionis Pharmaceuticals (IONS) reported operating margin of -33.3% in Q1 2026.
- How has Ionis Pharmaceuticals's operating margin changed year-over-year?
- Ionis Pharmaceuticals's operating margin increased by 49.5% year-over-year, from -65.9% to -33.3%.
- What is the long-term trend for Ionis Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's operating margin has grown at a 11.4% compound annual growth rate (CAGR), from -23.6% to -40.4%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.